TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 187 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $36,314,000 | +523.1% | 206,800 | -65.6% | 8.27% | +416.2% |
| Q2 2021 | $5,828,000 | +13.4% | 600,788 | +25.6% | 1.60% | +19.6% |
| Q1 2021 | $5,138,000 | -46.7% | 478,374 | -27.0% | 1.34% | -61.5% |
| Q4 2020 | $9,646,000 | +82.3% | 655,741 | +76.1% | 3.48% | +122.3% |
| Q3 2020 | $5,292,000 | -3.5% | 372,401 | -45.1% | 1.56% | +419.9% |
| Q2 2020 | $5,484,000 | +184.1% | 677,823 | +41.9% | 0.30% | -65.6% |
| Q1 2020 | $1,930,000 | +434.6% | 477,704 | +1857.8% | 0.88% | +553.0% |
| Q3 2016 | $361,000 | +47.3% | 24,400 | -10.6% | 0.13% | +63.4% |
| Q2 2016 | $245,000 | +111.2% | 27,300 | +118.4% | 0.08% | +115.8% |
| Q1 2016 | $116,000 | -26.6% | 12,500 | 0.0% | 0.04% | -28.3% |
| Q4 2015 | $158,000 | – | 12,500 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 701,138 | $4,067,000 | 0.67% |
| Matrix Capital Management Company, LP | 2,288,560 | $13,274,000 | 0.33% |
| NEA Management Company, LLC | 1,250,000 | $7,250,000 | 0.31% |
| Stanley-Laman Group, Ltd. | 139,403 | $809,000 | 0.20% |
| Cormorant Asset Management, LP | 500,000 | $2,900,000 | 0.19% |
| Tekla Capital Management LLC | 468,399 | $2,717,000 | 0.10% |
| Wealth Alliance Advisory Group, LLC | 21,800 | $126,000 | 0.06% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 175,339 | $1,007,000 | 0.03% |
| Artal Group S.A. | 150,000 | $870,000 | 0.02% |
| Baker Brothers Advisors | 505,262 | $2,931,000 | 0.02% |